Verorab

Verorab is an inactivated rabies virus vaccine used for pre- and post-exposure prophylaxis against rabies. This EU-manufactured vaccine provides immunization through intradermal or intramuscular administration. It is designed to stimulate the immune system to produce antibodies against the rabies virus.

Verorab is used to prevent rabies infection in individuals exposed to the virus or at high risk of exposure. It is commonly administered after a potential rabies exposure, such as animal bites, to provide immediate protection. The vaccine may also be used for pre-exposure prophylaxis in travelers or individuals working with animals. Verorab helps the body build immunity against the rabies virus.

Verorab works by prompting the immune system to produce antibodies that target the rabies virus. After administration, the body recognizes the inactivated virus particles and develops a protective response. Common effects include mild local reactions at the injection site, such as redness or swelling. Some individuals may experience mild systemic effects like fatigue or headache.

Verorab should be handled and administered by a healthcare professional. Individuals with a known allergy to any component of the vaccine should avoid its use. Pregnant or breastfeeding individuals should consult a healthcare provider before receiving the vaccine. Keep the vaccine refrigerated and protect it from light until use.

Verorab may interact with immunosuppressive therapies, such as corticosteroids or chemotherapy, which can reduce its effectiveness. Live vaccines should not be administered simultaneously with Verorab due to potential interference with immune response. Always inform your healthcare provider about any medications or vaccines you are currently taking.